Retrospective Encore Reverse Shoulder Prosthesis Study
Completed
- Conditions
- Rotator Cuff DeficiencyGlenohumeral Arthritis
- Interventions
- Device: Encore Reverse Shoulder Prosthesis
- Registration Number
- NCT00765037
- Lead Sponsor
- Encore Medical, L.P.
- Brief Summary
The purpose of this study is to evaluate the survivorship and efficacy of the Encore Reverse Shoulder Prosthesis in a group of no more than 50 subjects for whom data collection has already begun.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 19
Inclusion Criteria
- The RSP is indicated for use in patients with a grossly rotator cuff deficient shoulder joint with severe arthropathy or a previously failed joint replacement with a grossly rotator cuff deficient shoulder joint.
- The patient's joint must be anatomically and structurally suited to receive the selected implant(s), and a functional deltoid muscle is necessary to use the device.
- The glenoid baseplate is intended for Cementless application with the addition of screws for fixation. The humeral stem is intended for cemented use only.
Exclusion Criteria
- Infection or sepsis
- Insufficient bone quality which may affect the stability of the implant, as determined by the physician
- Muscular, neurological, or vascular deficiencies, which compromise the affected extremity
- Alcoholism or other addictions
- Materials (metals, etc) sensitivity
- Loss of ligamentous structures
- High levels of physical activity
- Non-functional deltoid muscle
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Encore RSP Encore Reverse Shoulder Prosthesis Subjects who need treatment for rotator cuff deficiency or glenohumeral arthritis, received the Encore Reverse Shoulder Prosthesis and are willing to participate in the study.
- Primary Outcome Measures
Name Time Method Survivorship of the Encore Reverse Shoulder Prosthesis 1 year Number of subjects who completed all study visits through the 1 year visit.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Nashville Orthopedic Specialists
šŗšøNashville, Tennessee, United States